Searched for
SHIRE PHARMACEUTICALS
Chief of Asia's largest pharmaceutical company urges transparency in virus vaccine rolloutTakeda, one of the world's biggest pharmaceutical companies, is not developing its own vaccine but has contracts with several firms to dist...- Nikkei snaps 7-day losing streak helped by China's stimulus hopesThe Nikkei share average ended 0.6% higher at 21,288.56, after trading in negative territory.
- Samurai sunrise: Japanese bank MUFG is the new go-to financier for who's who of India IncFor once, India's favourite bankroller is not a Wall Street bank, nor a Swiss or a blueblooded British one.
- Nikkei tracks sharp Wall Street gains; machinery, exporters attract gainsThe Nikkei share average added 2.4 percent to 20,038.97, rebounding from a sharp 2.3-percent drop on its first trading session this year on...
- Disappointing Fed drags European shares back to 2016 levelsThe STOXX 600 is set for its worst yearly performance since 2008, having fallen more than 13 percent year-to-date.
- Japanese stocks follow Wall St down; Topix close at a 19-month lowThe broader Topix closed 1.99 percent lower at 1,562.51, its weakest point since May 2017.
- Nikkei extends rally to 8th session as US rate hike hopes lift large capsThe Nikkei share average gained 0.4 per cent to 24,033.79.
- The big short. Bearish bets on biggest tech stocks hit $37 billionThe greater the rise, the greater the fall, so they are being targeted as the stocks to short.
- 'Indian IP and liabilities law barrier to pharma R&D investment'India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that preve...
- How billionaire father-son duo turned family firm into world beaterLast month Pankaj Patel announced his more than 20-years running the company were over.
- US court rules in favour of Zydus Cadila in patent caseThe US Court of Appeals for the Federal Circuit has affirmed judgement in favour of Zydus Pharmaceuticals (USA) Inc.
- Five mega global deals of 2016Microsoft’s deal to buy professional social network LinkedIn for $26.2bn officially closed after the European Commission cleared the acquis...
- Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billionHyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...
- FTSE dragged down by Wolseley, healthcare despite mining reboundThe FTSE 100 index was down 0.8 per cent at 5,909.24 points at its close, underperforming the broader pan-European FTSEurofirst 300.
- Britain's FTSE gains as cheaper oil helps cruise operator CarnivalGKN rose 2.6 per cent, leading the gains in the FTSE 100 , after Credit Suisse raised its price target for the stock to 410 pence from 380 ...
- Infosys founder NS Raghavan's venture investing arm invests Rs 100 crore in ConnexiosIn 2003, Nadathur Holdings, the venture investing arm of NS Raghavan, made its first investment in Connexios, a small drug discovery startu...
- Stocks to watch: Reliance Industries, Hero Honda, HCL Tech, Reliance InfrastructureReliance Industries, freed from its non-compete agreement with the Anil Dhirubhai Ambani Group (ADAG) that barred it from investing in high...
- Zydus arm, Irish co in patent disputeThe Rs 3,700-crore Zydus Group’s US subsidiary Zydus Pharmaceuticals USA has challenged the Irish company Shire Pharmaceuticals over its pa...
- Big Pharma seeks biotech dose to spur growthVincent Aita of Kilkenny Capital Management says he picks biotechnology stocks on their potential as takeover targets.
Load More
